SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-21-015766
Filing Date
2021-06-30
Accepted
2021-06-30 17:30:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D 63549
  Complete submission text file 0001493152-21-015766.txt   65156
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-32172 | Film No.: 211062945
SIC: 2834 Pharmaceutical Preparations

Mailing Address PROVECTUS PHARMACEUTICALS INC 7327 OAK RIDGE HIGHWAY KNOXVILLE TN 37931
Business Address
WACHTER ERIC PHD (Filed by) CIK: 0001124261 (see all company filings)

Type: SC 13D